Brand Details
Novo Nordisk
– Founded 1923
HQ: Bagsværd, Denmark
Website: https://www.novonordisk.com
Segments: Pharmaceuticals, Diabetes Care
A leading global healthcare company specializing in diabetes care.
About the Seller / Brand
| Company | Novo Nordisk |
|---|---|
| Website | https://www.novonordisk.com |
| HQ | Bagsværd, Denmark |
| Phone | +45 4444 8888 |
| Company LinkedIn | |
| Glassdoor | Glassdoor |
| Address | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, Denmark |
| Verified | 90% confidence (data from AI) |
Company Journey
| 1923 | Founded as Nordisk Insulin Company. |
| 1989 | Merged with Novo Industries to form Novo Nordisk. |
| 1999 | Launched the first insulin pen. |
| 2000s | Expanded focus to diabetes care and biopharmaceuticals. |
| 2015 | Acquired the rights to the diabetes drug Tresiba. |
| 2020 | Continued expansion in diabetes and obesity treatment. |
Novo Nordisk is a global healthcare company specializing in diabetes care, hemophilia, growth hormone therapy, and hormone replacement therapy. It has a strong commitment to sustainability and innovation in diabetes management.
Confidence: 100%
A leading global healthcare company specializing in diabetes care.
HQ: Bagsværd, Denmark
Founded: 1923
Parent Brand:
Segments: Pharmaceuticals, Diabetes Care
